Treating cancer cachexia to treat cancer

Se Jin Lee, David J. Glass

Research output: Contribution to journalArticle

Abstract

Skeletal muscle wasting is a major component of cachectic states found in a variety of disease settings, including cancer. As increasing caloric intake often provides little benefit in combating muscle loss in cachectic patients, a major research focus has been to develop strategies stimulating muscle anabolic pathways - in an attempt to fight the catabolic pathways induced during cachexia. Two recent papers have reported the beneficial effects of blocking the myostatin/activin signalling pathway in mouse models of cancer cachexia. We discuss the implications of their findings both with respect to the role that this signalling pathway may play in the aetiology of cachexia and with respect to the prospects for targeting this pathway as a therapeutic strategy in patients with cachexia.

Original languageEnglish (US)
Article number2
JournalSkeletal Muscle
Volume1
Issue number1
DOIs
StatePublished - Jan 24 2011

Fingerprint

Cachexia
Neoplasms
Myostatin
Activins
Muscles
Energy Intake
Skeletal Muscle
Research
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology
  • Orthopedics and Sports Medicine

Cite this

Treating cancer cachexia to treat cancer. / Lee, Se Jin; Glass, David J.

In: Skeletal Muscle, Vol. 1, No. 1, 2, 24.01.2011.

Research output: Contribution to journalArticle

Lee, Se Jin ; Glass, David J. / Treating cancer cachexia to treat cancer. In: Skeletal Muscle. 2011 ; Vol. 1, No. 1.
@article{ee56b9ac8cd54bdb8a410785f1a9da8e,
title = "Treating cancer cachexia to treat cancer",
abstract = "Skeletal muscle wasting is a major component of cachectic states found in a variety of disease settings, including cancer. As increasing caloric intake often provides little benefit in combating muscle loss in cachectic patients, a major research focus has been to develop strategies stimulating muscle anabolic pathways - in an attempt to fight the catabolic pathways induced during cachexia. Two recent papers have reported the beneficial effects of blocking the myostatin/activin signalling pathway in mouse models of cancer cachexia. We discuss the implications of their findings both with respect to the role that this signalling pathway may play in the aetiology of cachexia and with respect to the prospects for targeting this pathway as a therapeutic strategy in patients with cachexia.",
author = "Lee, {Se Jin} and Glass, {David J.}",
year = "2011",
month = "1",
day = "24",
doi = "10.1186/2044-5040-1-2",
language = "English (US)",
volume = "1",
journal = "Skeletal Muscle",
issn = "2044-5040",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Treating cancer cachexia to treat cancer

AU - Lee, Se Jin

AU - Glass, David J.

PY - 2011/1/24

Y1 - 2011/1/24

N2 - Skeletal muscle wasting is a major component of cachectic states found in a variety of disease settings, including cancer. As increasing caloric intake often provides little benefit in combating muscle loss in cachectic patients, a major research focus has been to develop strategies stimulating muscle anabolic pathways - in an attempt to fight the catabolic pathways induced during cachexia. Two recent papers have reported the beneficial effects of blocking the myostatin/activin signalling pathway in mouse models of cancer cachexia. We discuss the implications of their findings both with respect to the role that this signalling pathway may play in the aetiology of cachexia and with respect to the prospects for targeting this pathway as a therapeutic strategy in patients with cachexia.

AB - Skeletal muscle wasting is a major component of cachectic states found in a variety of disease settings, including cancer. As increasing caloric intake often provides little benefit in combating muscle loss in cachectic patients, a major research focus has been to develop strategies stimulating muscle anabolic pathways - in an attempt to fight the catabolic pathways induced during cachexia. Two recent papers have reported the beneficial effects of blocking the myostatin/activin signalling pathway in mouse models of cancer cachexia. We discuss the implications of their findings both with respect to the role that this signalling pathway may play in the aetiology of cachexia and with respect to the prospects for targeting this pathway as a therapeutic strategy in patients with cachexia.

UR - http://www.scopus.com/inward/record.url?scp=84864019439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864019439&partnerID=8YFLogxK

U2 - 10.1186/2044-5040-1-2

DO - 10.1186/2044-5040-1-2

M3 - Article

C2 - 21798080

AN - SCOPUS:84864019439

VL - 1

JO - Skeletal Muscle

JF - Skeletal Muscle

SN - 2044-5040

IS - 1

M1 - 2

ER -